Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
4 studies found for:    Open Studies | "Nystagmus, Pathologic"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Available Expanded Access Study of Amifampridine Phosphate in LEMS, Congenital Myasthenic Syndrome, or Downbeat Nystagmus Patients
Conditions: Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
Intervention: Drug: Amifampridine Phosphate
2 Recruiting Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism
Conditions: Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
Intervention:
3 Recruiting Bupivacaine Injection of Eye Muscles to Treat Strabismus
Conditions: Strabismus;   Esotropia;   Exotropia;   Graves Disease;   Nystagmus
Intervention: Drug: Bupivacaine
4 Recruiting Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo
Condition: Benign Paroxysmal Positional Vertigo (BPPV)
Intervention: Procedure: Canalith repositioning maneuver
To Top

† Indicates status has not been verified in more than two years